We tested this hypothesis by co-immunoprecipitation from U87MG human glioblastoma cells as this cell line has higher expression levels of SBP2L compared to more commonly used cells lines (i.e. HeLa, HEK293) according to microarray data from the human gene atlas available through BioGPS [22], [23]. The gene discussed is SECISBP2L; the disease is glioblastoma.